glp 1 therapies GLP-1-based therapies, including GLP-1, GLP-1R agonists and DPP-4 GLP-1 Agonists For Obesity In

There is evidence suggesting that various stimulating factors such as adrenaline, insulin, and hypoxia can cause the phosphorylation of PFKFB2 protein in the myocardium, thereby increasing the concentration of 2,6-diphosphofructose and promoting the glycolysis process

The Type 2 Diabetes Cohort Also Favored GLP-1 RAs Against Insulin or Metformin The signal became even more dramatic in the comparison between GLP-1 receptor agonists and insulin or metformin among patients with type 2 diabetes

Here's what the evidence suggests

Scientists still arent sure why this happens and havent yet developed a cure, but we know that inflammation is a huge factor and that oxidative stress is often the culprit

Shimizu, K